A promising new drug could put an end to cumbersome CPAP machines and allow millions of Americans to breathe easy and sleep soundly. Researchers at the biopharm company Apnimed have been developing a ...

A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...

In today's medical science, one of the most advanced and effective processes to treat health problems like Type 2 diabetes, ...

AD109 works by targeting neuromuscular dysfunction of upper airway muscles during sleep, representing a potential new ...

A University of Toronto professor’s research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently reported positive results in a phase 3 clinical ...

A University of Toronto professor's research on the physiology of sleep and breathing has paved the way for a new sleep apnea treatment that recently ...

GIP drugs such as tirzepatide (Mounjaro, Zepbound) are transforming metabolic health. Learn how they work, their uses, and ...

Sleep apnea affects approximately 1 out of 8 people worldwide, and people often remain in the dark about what’s going on.

If you’ve struggled with restless nights, exhaustion that no amount of sleep seems to fix, or a partner who says your snoring is out of control, the conversation around Ozempic and other GLP-1 drugs ...

Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says By Dennis Thompson HealthDay ReporterWEDNESDAY, May 20, 2026 (HealthDay News) — Some people with sleep apnea might ...

The new treatment could hit the market as early as 2027.

A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ATS International Conference. The drug, called AD109, is the first therapy to ...